Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

63.10 -2.27 (-3.47%)
Streaming Delayed Price Updated: 1:21 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,633,132
Open 64.44
Bid (Size) 63.09 (9)
Ask (Size) 63.10 (13)
Prev. Close 65.37
Today's Range 62.92 - 64.47
52wk Range 52.65 - 72.12
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
These healthcare titans are poised for a strong showing in 2023 and beyond. 
Via The Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. 
Via Benzinga

Performance

YTD
-8.99%
-8.99%
1 Month
-8.99%
-8.99%
3 Month
+5.43%
+5.43%
6 Month
-3.31%
-3.31%
1 Year
+8.40%
+8.40%

More News

Read More
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Via MarketBeat
Exposures Product Safety
Could This Vaccine Become Sanofi's Latest Blockbuster?
Via The Motley Fool
Could This Be Novartis' Next Blockbuster Medicine?
Via The Motley Fool
AZN Stock Under Pressure
Via Talk Markets
The Top Healthcare Stocks to Buy With $100
Via The Motley Fool
7 Dividend Stocks to Buy for a Stable Income Stream
Via InvestorPlace
Mergers and Acquisitions in 2023 Off To A Strong Start
Via MarketBeat
Exposures Product Safety
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Via The Motley Fool
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
From AstraZeneca
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
From Brodsky & Smith LLC
Via Globe NewsWire
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
Via Investor's Business Daily
AstraZeneca’s Next “Wonder Drug”
Via Talk Markets
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
Via FinancialNewsMedia
Exposures COVID-19 Product Safety
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
From HUTCHMED (China) Limited
Via Globe NewsWire
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Via MarketBeat
Topics Stocks
Exposures US Equities
Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices
Via Talk Markets
The Viral “Tripledemic” Opportunity
Via Talk Markets
3 Growth Stocks Poised for Huge Gains in 2023
Via The Motley Fool
Why These Two Biotech Stocks Blasted Higher This Week
Via The Motley Fool
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Via Investor's Business Daily
Could This New Drug Launch Be a Hit for Viatris?
Via The Motley Fool
AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.